Oxcarbazepine Use in Paroxysmal Kinesigenic Dyskinesia: Report on Four Patients

Pediatric Neurology

Volumn 40, Issue 4, 2009, Pages 295-297

  Chillag, Kipp L ^a   DeRoos, Steven T ^a  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBIDOPA PLUS LEVODOPA; ETIRACETAM; LICARBAZEPINE; OXCARBAZEPINE; TOPIRAMATE; UBIDECARENONE; VALPROIC ACID;

ADOLESCENT; ALLERGIC RASH; ARTICLE; CASE REPORT; CHILD; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSKINESIA; ELECTROENCEPHALOGRAM; EVENING DOSAGE; FEMALE; GENETIC ANALYSIS; HEADACHE; HUMAN; KINESIGENIC DYSKINENIA; LABORATORY TEST; LOW DRUG DOSE; MALE; MIGRAINE; MONOTHERAPY; MORNING DOSAGE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; ANTI-DYSKINESIA AGENTS; CARBAMAZEPINE; CHILD; DEVELOPMENTAL DISABILITIES; DYSKINESIAS; EMOTIONS; FEMALE; HUMANS; MALE; MIGRAINE WITH AURA; NEUROLOGIC EXAMINATION; STEREOTYPED BEHAVIOR;

EID: 62549141492     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.09.024     Document Type: Article

References (15)

1. Bruno M.K., Hallett M., Gwinn-Hardy K., et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: New diagnostic criteria. Neurology 63 (2004) 2280-2287
2. Demirkiran M., and Jankovic J. Paroxysmal dyskinesias: Clinical features and classification. Ann Neurol 38 (1995) 571-579
3. Zorzi G., Conti C., Erba A., Granata T., Angelini L., and Nardocci N. Paroxysmal dyskinesias in childhood. Pediatr Neurol 28 (2003) 68-172
4. Pandy H.K., and Riggs J.E. Channelopathies in pediatric neurology. Neurol Clin 21 (2003) 765-777
5. Chen D.H., Matsushita M., Ranier S., et al. Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: Confirmation in 2 kindreds. Arch Neurol 62 (2005) 597-600
6. Margari L., Presicci A., Ventura P., Margari F., and Perniola T. Channelopathy: Hypothesis of a common pathophysiologic mechanism in different forms of paroxysmal dyskinesia. Pediatr Neurol 32 (2005) 229-235
7. Kertesz A. Paroxysmal kinesigenic choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 17 (1967) 680-690
8. Guerrini R. Idiopathic epilepsy and paroxysmal dyskinesia. Epilepsia 42 Suppl. 3 (2001) 36-41
9. Ohmori I., Ohtsuka Y., Ogino T., Yoshinaga H., Kobayashi K., and Oka E. The relationship between paroxysmal kinesigenic choreoathetosis and epilepsy. Neuropediatrics 33 (2002) 15-20
10. Glauser T.A., Nigro M., Sachdeo R., et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 54 (2000) 2237-2244
11. Northam R.S., Hernandez A.W., Litzinger M.J., et al. Oxcarbazepine in infants and young children with partial seizures. Pediatr Neurol 33 (2005) 337-344
12. Vasquez B. Monotherapy in epilepsy: Role of newer antiepileptic drugs. Arch Neurol 61 (2004) 1361-1365
13. Gokcay A., and Gakcay F. Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis. Acta Neurol Scand 101 (2000) 344-345
14. Tsao C.Y. Effective treatment with oxcarbazepine in paroxysmal kinesigenic choreoathetosis. J Child Neurol 19 (2004) 300-301
15. Iglesias-Gomez S., et al. Oxcarbazepine in the treatment of kinesigenic paroxysmal choreoathetosis. [in French]. Rev Neurol 41 (2005) 314-316